Works matching DE "RIVAROXABAN"

Results: 1565

A comparative study in patients with fractures of the lower limbs between rivaroxaban versus enoxaparin and its impact on bone healing time.

Published in:

Acta Ortopédica Mexicana, 2017, v. 31, n. 4, p. 177

By:

P., Peláez-Damy;
A., Torres-Gómez;
F., Mas-Celis;
M., Martínez-Villalobos

Publication type:

Article

Compatibility study of rivaroxaban and its pharmaceutical excipients.

Published in:

Journal of Thermal Analysis & Calorimetry, 2017, v. 130, n. 3, p. 1569, doi. 10.1007/s10973-017-6412-3

By:

Zhai, Li-Hai;
Ding, Ting;
Chen, Lan;
Sun, Bai-Wang;
Fu, Yan

Publication type:

Article

Comparing the Clinical Outcomes Observed with Rivaroxaban Versus Warfarin for the Management of Obese Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 1, p. 79, doi. 10.1007/s10557-022-07361-9

By:

Zhuo, Xiaojun;
Wang, Jian;
Shao, Lihui

Publication type:

Article

Rivaroxaban After Transcatheter Aortic Valve Replacement: A Critical Appraisal of the GALILEO Trial.

Published in:

Cardiovascular Drugs & Therapy, 2023, v. 37, n. 6, p. 1239, doi. 10.1007/s10557-022-07350-y

By:

Sulzgruber, Patrick;
Hammer, Andreas;
Niessner, Alexander

Publication type:

Article

Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore.

Published in:

Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 917, doi. 10.1007/s10557-022-07346-8

By:

Soh, Xin Qin;
Tan, Doreen Su-Yin;
Chan, Eric Chun Yong

Publication type:

Article

Model-Based Risk Prediction of Rivaroxaban with Amiodarone for Moderate Renal Impaired Elderly Population.

Published in:

Cardiovascular Drugs & Therapy, 2023, v. 37, n. 3, p. 605, doi. 10.1007/s10557-021-07266-z

By:

Wang, Ziteng;
Cheong, Eleanor Jing Yi;
Kojodjojo, Pipin;
Chan, Eric Chun Yong

Publication type:

Article

Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant.

Published in:

Cardiovascular Drugs & Therapy, 2022, v. 36, n. 1, p. 121, doi. 10.1007/s10557-020-07129-z

By:

Zhao, Tingting;
Chen, Yanwei;
Wang, Dalong;
Wang, Liyan;
Dong, Peipei;
Zhao, Shan;
Wang, Changyuan;
Meng, Qiang;
Sun, Huijun;
Liu, Kexin;
Wu, Jingjing

Publication type:

Article

Rationale and Design of the H-REPLACE Study: Safety and Efficacy of LMWH Versus Rivaroxaban in ChinEse Patients HospitaLized with Acute Coronary SyndromE.

Published in:

Cardiovascular Drugs & Therapy, 2022, v. 36, n. 1, p. 69, doi. 10.1007/s10557-020-07076-9

By:

Xiao, Yichao;
Tang, Liang;
Liu, Qiming;
Hu, Xinqun;
Fang, Zhenfei;
Zhou, Shenghua

Publication type:

Article

Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 533, doi. 10.1007/s10557-020-07061-2

By:

Kataruka, Akash;
Mahtta, Dhruv;
Akeroyd, Julia M.;
Hira, Ravi S.;
Kazi, Dhruv S.;
Spertus, John A.;
Bhatt, Deepak L.;
Petersen, Laura A.;
Ballantyne, Christie M.;
Virani, Salim S.

Publication type:

Article

Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 539, doi. 10.1007/s10557-020-07059-w

By:

Lee, Mei-Chuan;
Liao, Chia-Te;
Toh, Han Siong;
Chou, Chih-Chen;
Chang, Wei-Ting;
Chen, Zhih-Cherng;
Wu, Wen-Shiann;
Yu, Tsung;
Strong, Carol

Publication type:

Article

Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on Dialysis.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 2, p. 273, doi. 10.1007/s10557-021-07144-8

By:

Chen, Chen;
Cao, Yalin;
Zheng, Ying;
Dong, Yugang;
Ma, Jianyong;
Zhu, Wengen;
Liu, Chen

Publication type:

Article

Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients.

Published in:

Cardiovascular Drugs & Therapy, 2019, v. 33, n. 3, p. 331, doi. 10.1007/s10557-019-06872-2

By:

Fung, Ka-Po;
Chan, Kei-Hong;
Ng, Vivien;
Tsui, Ping-Tim;
You, Joyce H. S.

Publication type:

Article

Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants.

Published in:

Cardiovascular Drugs & Therapy, 2016, v. 30, n. 2, p. 201, doi. 10.1007/s10557-015-6632-3

By:

Morais, João;
De Caterina, Raffaele

Publication type:

Article

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation.

Published in:

Cardiovascular Drugs & Therapy, 2014, v. 28, n. 6, p. 575, doi. 10.1007/s10557-014-6558-1

By:

Wang, Ye;
Xie, Feng;
Kong, Ming;
Lee, Lai;
Ng, Heng;
Ko, Yu

Publication type:

Article

A Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban.

Published in:

Molecules, 2014, v. 19, n. 9, p. 14999, doi. 10.3390/molecules190914999

By:

Jianyong Yuan;
Kai Liu;
Lun Li;
Yong Yuan;
Xuelei Liu;
Yanwu Li

Publication type:

Article

Bioequivalence study of two formulations of rivaroxaban in healthy adult subjects under fasting conditions.

Published in:

American Journal of Pharmacotherapy & Pharmaceutical Sciences, 2023, p. 1, doi. 10.25259/AJPPS_2023_008

By:

Pena, Evelyn;
Inatti, Alfredo;
Martín, Xenón S.

Publication type:

Article

Anticoagulants in left atrial thrombus resolution.

Published in:

Annals of Medical Research, 2020, v. 27, n. 7, p. 1908, doi. 10.5455/annalsmedres.2020.03.284

By:

Yilmaz, Kerem Can;
Ciftci, Orcun;
Ozin, Bulent;
Muderrisoglu, Haldun

Publication type:

Article

Indian Real-world Evidence of Rivaroxaban Use in Coronary Artery Disease - A Prospective Observational Cohort Study (IN-RECORD): Study Design and Baseline Characteristics.

Published in:

Journal of the Practice of Cardiovascular Sciences, 2023, v. 9, n. 3, p. 172, doi. 10.4103/jpcs.jpcs_58_23

By:

Jayagopal, P. B.;
Raghuraman, Bagirath;
Khetan, Anup;
Magarkar, Vilas;
Premchand, Rajendra Kumar;
Ezhilan, J.;
Sharma, Vinod;
Kumar, A. Sreenivas;
Dabhade, Dhammdeep;
Shewale, Rishikesh;
Suryawanshi, Sachin;
Vikneswaran, G.

Publication type:

Article

Efficacy and Safety of Rivaroxaban in Prevention and Therapy of Thromboembolic Events in Patients with Nonvalvular Atrial Fibrillation.

Published in:

Journal of the Practice of Cardiovascular Sciences, 2023, v. 9, n. 2, p. 110, doi. 10.4103/jpcs.jpcs_40_23

By:

Preradovic, Tamara;
Miljković, Siniša;
Kos, Ljiljana;
Šukalo, Aziz;
Glamočlija, Una;
Avdić, Amna;
Mehić, Meliha

Publication type:

Article

Thrombosis of a biological pulmonary valve in a young patient on anticoagulant therapy with rivaroxaban: a case report.

Published in:

2019

By:

Strozzi, Maja;
Anic, Darko;
Baricevic, Zeljko;
Hrabak-Paar, Maja

Publication type:

Case Study

The benefits—and limits—of PPIs with warfarin regimens.

Published in:

2017

By:

Ludden-Schlatter, Alicia;
Stevermer, James J.;
Mounsey, Anne

Publication type:

Case Study

An alternative to warfarin for patients with PE.

Published in:

Journal of Family Practice, 2012, v. 61, n. 12, p. 751

By:

Morris, Laura;
Stevermer, James J.

Publication type:

Article

2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri‐operative and bleeding management.

Published in:

Internal Medicine Journal, 2025, v. 55, n. 7, p. 1174, doi. 10.1111/imj.70103

By:

Tran, Huyen A.;
Merriman, Eileen;
Baker, Ross;
Curnow, Jennifer;
Young, Laura;
Tan, Chee Wee;
McRae, Simon;
Chunilal, Sanjeev D.

Publication type:

Article

Rivaroxaban‐related nephropathy: an under‐reported cause of acute kidney injury.

Published in:

Internal Medicine Journal, 2025, v. 55, n. 5, p. 864, doi. 10.1111/imj.70080

By:

Marshall, Lucy;
Ahmed, Naveed;
de Zoysa, Janak R.;
Hayat, Ashik

Publication type:

Article

Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty.

Published in:

Internal Medicine Journal, 2024, v. 54, n. 8, p. 1275, doi. 10.1111/imj.16407

By:

van Oosterom, Nameer;
Barras, Michael;
Cottrell, Neil

Publication type:

Article

Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia.

Published in:

Internal Medicine Journal, 2024, v. 54, n. 6, p. 932, doi. 10.1111/imj.16329

By:

Lim, Ming S.;
Mohamed, Muhajir

Publication type:

Article

Real‐world decision‐making in the management of patients presenting with major bleeding on rivaroxaban: the Auckland regional experience.

Published in:

Internal Medicine Journal, 2023, v. 53, n. 8, p. 1444, doi. 10.1111/imj.15786

By:

Grainger, Brian T.;
Merriman, Eileen;
Royle, Gordon;
Eaddy, Nicola;
Ockelford, Paul;
Young, Laura

Publication type:

Article

Prothrombin complex concentrates for the urgent reversal of apixaban and rivaroxaban: an Australian retrospective cohort study.

Published in:

Internal Medicine Journal, 2023, v. 53, n. 5, p. 803, doi. 10.1111/imj.15621

By:

Wallwork, Stephanie;
Wang, Yang;
Chaiwatanatorn, Kritika;
Cole‐Sinclair, Merrole

Publication type:

Article

Safety first, a harmful interaction between rivaroxaban and berberine.

Published in:

2022

By:

Bonnichsen, Mark;
Stoklosa, Ted;
Bowen, David;
Majumdar, Avik

Publication type:

Letter to the Editor

Delayed cardiac tamponade from pericarditis following pulmonary vein cryo‐balloon ablation.

Published in:

2020

By:

Evans, Shaun;
Kadhim, Kadhim;
Emami, Mehrdad;
Baumann, Angus;
Roberts‐Thomson, Kurt C.;
Sanders, Prashanthan

Publication type:

Case Study

Direct Oral Anticoagulants: Presciption Errors and Adverse Outcomes.

Published in:: 2018
Publication type:: Abstract

Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thromboses.

Published in:

Internal Medicine Journal, 2018, v. 48, n. 1, p. 98, doi. 10.1111/imj.13665

By:

Balendran, Shalini;
Harrison, Alexander;
Morel‐Kopp, Marie‐Christine;
Ward, Christopher;
Forsyth, Cecily

Publication type:

Article

Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker.

Published in:

Translational & Clinical Pharmacology, 2017, v. 25, n. 3, p. 138, doi. 10.12793/tcp.2017.25.3.138

By:

Shi Hyun Rhew;
Sung Soo Kim

Publication type:

Article

Postoperative Bleeding in Patients Under Direct Oral Anticoagulation After Maxillary Sinus Floor Augmentation: A Case-Control Study.

Published in:

International Journal of Oral & Maxillofacial Implants, 2022, v. 37, n. 2, p. 365, doi. 10.11607/jomi.9247

By:

Capparè, Paolo;
Tetè, Giulia;
Alfieri, Ottavio;
Pantaleo, Giuseppe;
Montemezzi, Pietro

Publication type:

Article

Perioperative Management of the Direct-Acting Oral Anticoagulants.

Published in:

AANA Journal, 2019, v. 87, n. 4, p. 325

By:

Kane, Terri D.

Publication type:

Article

Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 12, p. 1872, doi. 10.1002/psp4.13036

By:

Terrier, Jean;
Gaspar, Frédéric;
Gosselin, Pauline;
Raboud, Olivier;
Lenoir, Camille;
Rollason, Victoria;
Csajka, Chantal;
Samer, Caroline;
Fontana, Pierre;
Daali, Youssef;
Reny, Jean‐Luc

Publication type:

Article

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug–drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 11, p. 1430, doi. 10.1002/psp4.12844

By:

Ngo, Lien Thi;
Yang, Sung‐yoon;
Shin, Sooyoung;
Cao, Duc Tuan;
Van Nguyen, Hung;
Jung, Sangkeun;
Lee, Jae‐Young;
Lee, Jong‐Hwa;
Yun, Hwi‐yeol;
Chae, Jung‐woo

Publication type:

Article

Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 8, p. 1111, doi. 10.1002/psp4.12830

By:

Willmann, Stefan;
Ince, Ibrahim;
Ahsman, Maurice;
Coboeken, Katrin;
Zhang, Yang;
Thelen, Kirstin;
Kubitza, Dagmar;
Zannikos, Peter;
Zhou, Wangda;
Pina, Liza Miriam;
Post, Teun;
Lippert, Jörg

Publication type:

Article

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1195, doi. 10.1002/psp4.12688

By:

Willmann, Stefan;
Coboeken, Katrin;
Zhang, Yang;
Mayer, Hannah;
Ince, Ibrahim;
Mesic, Emir;
Thelen, Kirstin;
Kubitza, Dagmar;
Lensing, Anthonie W. A.;
Yang, Haitao;
Zhu, Peijuan;
Mück, Wolfgang;
Drenth, Henk‐Jan;
Lippert, Jörg

Publication type:

Article

Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 11, p. 805, doi. 10.1002/psp4.12444

By:

Solms, Alexander;
Frede, Matthias;
Berkowitz, Scott D.;
Hermanowski‐Vosatka, Anne;
Kubitza, Dagmar;
Mueck, Wolfgang;
Spiro, Theodore E.;
Willmann, Stefan;
Yan, Xiaoyu;
Zhang, Liping;
Garmann, Dirk

Publication type:

Article

Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 5, p. 309, doi. 10.1002/psp4.12288

By:

Willmann, Stefan;
Zhang, Liping;
Frede, Matthias;
Kubitza, Dagmar;
Mueck, Wolfgang;
Schmidt, Stephan;
Solms, Alexander;
Yan, Xiaoyu;
Garmann, Dirk

Publication type:

Article

Issue Information.

Published in:: 2018
Publication type:: Table of Contents

Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of GCC-4401C, a Novel Direct Factor Xa Inhibitor, in Healthy Volunteers.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 10, p. 532, doi. 10.1002/psp4.12103

By:

Choi, HY;
Choi, S;
Kim, YH;
Lim, HS

Publication type:

Article

Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 10, p. 554, doi. 10.1002/psp4.12111

By:

Hartmann, S;
Biliouris, K;
Lesko, LJ;
Nowak‐Göttl, U;
Trame, MN

Publication type:

Article

FREQUENCY OF MAJOR BLEEDING EPISODES WITH RIVAROXABAN FOR ATRIAL FIBRILLATION RELATED STROKE PREVENTION IN CHRONIC KIDNEY DISEASE PATIENTS.

Published in:

Pakistan Heart Journal, 2022, v. 55, n. 1, p. 63, doi. 10.47144/phj.v55i1.2212

By:

Tahir, Sania;
Iqbal, Nasir;
Tahir, Muhammad Bilal;
Sultan, Imran;
Shafi, Sara;
Shahid, Omar

Publication type:

Article

The role of pharmacogenetics as a possible risk factor for rivaroxaban – associated bleeding.

Published in:

Cardiologia Croatica, 2022, v. 17, n. 9/10, p. 278, doi. 10.15836/ccar2022.278

By:

Slišković, Ana Marija;
Šimičević, Livija;
Kirhmajer, Majda Vrkić;
Ganoci, Lana;
Holik, Hrvoje;
Samardžić, Jure;
Božina, Tamara

Publication type:

Article

Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study.

Published in:

BMC Pharmacology & Toxicology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s40360-023-00712-8

By:

Ramos-Isaza, Estefan;
Tuta-Quintero, Eduardo;
Bastidas-Goyes, Alirio;
Diaz-Quijano, Diana;
Aponte-Murcia, Carolina;
Espitia-Angel, Julian;
Pinto-Beltran, Daniel;
Rincón-Hernández, Johan;
Sánchez-Cuellar, Juan;
Pérez-Bueno, Jesus;
Giraldo-Cadavid, Luis F.

Publication type:

Article

Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project.

Published in:

Life (2075-1729), 2022, v. 12, n. 11, p. 1725, doi. 10.3390/life12111725

By:

Bernardi, Enrico;
Camporese, Giuseppe;
Bortoluzzi, Cristiano;
Noventa, Franco;
Ceccato, Davide;
Tonello, Chiara;
Vohong, Stefania;
Campello, Elena;
Simion, Chiara;
Imbalzano, Egidio;
Di Micco, Pierpaolo;
Callegari, Elena;
Simioni, Paolo

Publication type:

Article

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project.

Published in:

Life (2075-1729), 2022, v. 12, n. 10, p. 1657, doi. 10.3390/life12101657

By:

Bortoluzzi, Cristiano;
Bernardi, Enrico;
Camporese, Giuseppe;
Noventa, Franco;
Ceccato, Davide;
Tonello, Chiara;
Vo Hong, Ngoc;
Campello, Elena;
Simion, Chiara;
Imbalzano, Egidio;
Di Micco, Pierpaolo;
Callegari, Elena;
Simioni, Paolo

Publication type:

Article

Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy.

Published in:

Life (2075-1729), 2022, v. 12, n. 8, p. 1128, doi. 10.3390/life12081128

By:

Di Micco, Pierpaolo;
Salazar, Vladimir Rosa;
Capitan, Carmen Fernandez;
Dentali, Francesco;
Cuervo, Covadonga Gomez;
Torres, Jose Luis Fernandez;
Porras, Jose Antonio;
Fidalgo, Angeles;
Grandone, Elvira;
Meseguer, Manuel Lopez;
Monreal, Manuel

Publication type:

Article